003017 大洋生物
交易中 08-14 14:23:42
资讯
新帖
简况
大洋生物：公司目前氟苯下游客户主要为医药及农药生产企业
证券之星 · 08-13 08:57
大洋生物：公司目前氟苯下游客户主要为医药及农药生产企业
大洋生物：氟苯与其它含氟芳香烃产品采用共线生产模式
证券之星 · 08-13 08:54
大洋生物：氟苯与其它含氟芳香烃产品采用共线生产模式
大洋生物：碳酸钾可应用于医药行业，用做药物合成工艺助剂、注射缓冲剂等
证券之星 · 08-13 08:51
大洋生物：碳酸钾可应用于医药行业，用做药物合成工艺助剂、注射缓冲剂等
大洋生物（003017）33.55万股限售股将于8月10日解禁，占总股本0.33%
证券之星 · 08-10
大洋生物（003017）33.55万股限售股将于8月10日解禁，占总股本0.33%
股市必读：大洋生物新发布《关于2025年股权激励计划授予的限制性股票第一个限售期解除限售并上市流通的提示性公告》
证券之星 · 08-07
股市必读：大洋生物新发布《关于2025年股权激励计划授予的限制性股票第一个限售期解除限售并上市流通的提示性公告》
大洋生物（003017）披露2025年股权激励计划限制性股票第一个限售期解除限售安排，8月5日股价上涨0.47%
证券之星 · 08-05
大洋生物（003017）披露2025年股权激励计划限制性股票第一个限售期解除限售安排，8月5日股价上涨0.47%
股市必读：大洋生物新发布《第六届董事会第十次会议决议公告》
证券之星 · 08-05
股市必读：大洋生物新发布《第六届董事会第十次会议决议公告》
股市必读：大洋生物新发布《第六届董事会第十次会议决议公告》
证券之星 · 08-04
股市必读：大洋生物新发布《第六届董事会第十次会议决议公告》
大洋生物（003017）披露2025年股权激励计划限制性股票第一个限售期解除限售条件成就公告，8月3日股价上涨2.66%
证券之星 · 08-03
大洋生物（003017）披露2025年股权激励计划限制性股票第一个限售期解除限售条件成就公告，8月3日股价上涨2.66%
股市必读：大洋生物（003017）7月15日董秘有最新回复
证券之星 · 07-16
股市必读：大洋生物（003017）7月15日董秘有最新回复
大洋生物：现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产
证券之星 · 07-15
大洋生物：现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产
大洋生物（003017）披露完成工商登记变更并换发营业执照公告，6月30日股价上涨7.03%
证券之星 · 06-30
大洋生物（003017）披露完成工商登记变更并换发营业执照公告，6月30日股价上涨7.03%
6月30日大洋生物涨7.03%，长城行业轮动混合A基金重仓该股
证券之星 · 06-30
6月30日大洋生物涨7.03%，长城行业轮动混合A基金重仓该股
大洋生物涨7.03%，开源证券二个月前给出“买入”评级
证券之星 · 06-30
大洋生物涨7.03%，开源证券二个月前给出“买入”评级
大洋生物（003017）披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告，6月26日股价上涨0.19%
证券之星 · 06-26
大洋生物（003017）披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告，6月26日股价上涨0.19%
大洋生物：现阶段相关产线正常生产，订单承接有序
证券之星 · 06-24
大洋生物：现阶段相关产线正常生产，订单承接有序
大洋生物：下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线
证券之星 · 06-24
大洋生物：下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线
大洋生物：山东大洋新材料子公司预计2026年8-9月开始投产
证券之星 · 06-24
大洋生物：山东大洋新材料子公司预计2026年8-9月开始投产
大洋生物：现阶段暂无进一步收购股权的相关计划
证券之星 · 06-24
大洋生物：现阶段暂无进一步收购股权的相关计划
大洋生物：除本公司与美国辉宝外全球暂未出现同等规模量产能力的第三方厂商
证券之星 · 06-24
大洋生物：除本公司与美国辉宝外全球暂未出现同等规模量产能力的第三方厂商
加载更多
公司概况
公司名称：
浙江大洋生物科技集团股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2020-10-26
主营业务：
浙江大洋生物科技集团股份有限公司的主营业务是基础化学原料制造和销售、化学产品制造和销售。公司的主要产品是无机盐产品、精细化工产品。公司是国家级专精特新“小巨人”。
发行价格：
28.85
{"stockData":{"symbol":"003017","market":"SZ","secType":"STK","nameCN":"大洋生物","latestPrice":22.24,"timestamp":1786688622000,"preClose":21.71,"halted":0,"volume":3559660,"delay":0,"changeRate":0.0244,"floatShares":83481100,"shares":101000000,"eps":1.0058,"marketStatus":"交易中","change":0.53,"latestTime":"08-14 14:23:42","open":21.66,"high":23.33,"low":21.61,"amount":79967600,"amplitude":0.0792,"askPrice":22.24,"askSize":145,"bidPrice":22.23,"bidSize":48,"shortable":0,"etf":0,"ttmEps":1.0058,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1786690800000},"marketStatusCode":2,"adr":0,"adjPreClose":21.71,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":23.88,"lowLimit":19.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":100800000,"isCdr":false,"pbRate":1.88,"roa":"--","peRate":22.111752,"roe":"2.68%","epsLYR":1.2257,"committee":-0.279152,"marketValue":2242000000,"turnoverRate":0.0426,"status":0,"floatMarketCap":1857000000},"requestUrl":"/m/hq/s/003017","defaultTab":"news","newsList":[{"id":"2659181014","title":"大洋生物：公司目前氟苯下游客户主要为医药及农药生产企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2659181014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659181014?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:57","pubTimestamp":1786582628,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，根据公开化工资料，氟苯理论上可用作锂电池电解液溶剂、电子新材料中间体。请问公司对外销售的氟苯产品，当前下游客户是否覆盖锂电池电解液、电子新材料相关行业？大洋生物回复：尊敬的投资者，您好。公司目前氟苯下游客户主要为医药及农药生产企业。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300006971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","003017","BK0229","09939","BK1574","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659810621","title":"大洋生物：氟苯与其它含氟芳香烃产品采用共线生产模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2659810621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659810621?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:54","pubTimestamp":1786582453,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司的氟苯柔性生产线正常排产状态下，稳定年产量大约多少吨？产品目前对外销售的下游覆盖哪些行业客户？大洋生物回复：尊敬的投资者，您好。公司氟苯与其它含氟芳香烃产品采用共线生产模式，生产线整体设计产能为1500吨/年。公司结合市场供需行情灵活调节各品类产出，实现装置效益最大化。现阶段氟苯产品主要下游客户为农药及医药原料生产制造企业。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300006766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659181217","title":"大洋生物：碳酸钾可应用于医药行业，用做药物合成工艺助剂、注射缓冲剂等","url":"https://stock-news.laohu8.com/highlight/detail?id=2659181217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659181217?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:51","pubTimestamp":1786582305,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问贵司的医药级碳酸钾项目目前是处于小试还是中试？预计何时完成工艺验证？对比现有工业级碳酸钾，医药级碳酸钾能够拓展哪些全新下游应用领域？项目研发落地后，公司是否已经开展下游客户送样工作？大洋生物回复：尊敬的投资者，您好。公司碳酸钾规格主要有优等品、一等品、合格品及食品添加剂级。碳酸钾可应用于医药行业，用做药物合成工艺助剂、注射缓冲剂等。公司碳酸钾下游客户涵盖医药、农药、农业、工业生产等方面。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300006618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658051306","title":"大洋生物（003017）33.55万股限售股将于8月10日解禁，占总股本0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658051306","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658051306?lang=zh_cn&edition=full","pubTime":"2026-08-10 08:02","pubTimestamp":1786320127,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，大洋生物于8月10日将有33.55万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.33%。本次解禁后，公司还有1731.89万股限售股份，占总股本17.18%。大洋生物主营业务：主要从事无机盐、兽用原料药等化学原料产品的生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665115","title":"股市必读：大洋生物新发布《关于2025年股权激励计划授予的限制性股票第一个限售期解除限售并上市流通的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657665115?lang=zh_cn&edition=full","pubTime":"2026-08-07 02:09","pubTimestamp":1786039754,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，大洋生物报收于21.72元，上涨1.02%，换手率1.52%，成交量1.26万手，成交额2702.32万元。公司公告汇总：大洋生物2025年股权激励计划第一个限售期解除限售股份596,442股，占总股本0.5917%，将于2026年8月10日上市流通。本次解除限售股份数量为596,442股，占公司总股本的0.5917%，涉及激励对象7人，包括董事、高级管理人员及核心技术（业务）人员。公司层面和个人层面考核均达标，相关董事会及薪酬与考核委员会已审议通过解除限售事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657950523","title":"大洋生物（003017）披露2025年股权激励计划限制性股票第一个限售期解除限售安排，8月5日股价上涨0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657950523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657950523?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:32","pubTimestamp":1785940336,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，大洋生物报收于21.5元，较前一交易日上涨0.47%，最新总市值为21.67亿元。该股当日开盘21.5元，最高21.7元，最低21.2元，成交额达3920.61万元，换手率为2.19%。公告显示，公司2025年股权激励计划授予的限制性股票第一个限售期已于2026年7月22日届满，解除限售条件已成就。解除限售股份的上市流通日期为2026年8月10日。公司层面和个人层面考核均达标，相关董事会及薪酬与考核委员会已审议通过解除限售事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657256324","title":"股市必读：大洋生物新发布《第六届董事会第十次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657256324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657256324?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:12","pubTimestamp":1785867134,"startTime":"0","endTime":"0","summary":"相关议案已获董事会薪酬与考核委员会审议通过，关联董事已回避表决。董事会及薪酬与考核委员会确认本次解除限售合法合规。关于调整2025年股权激励计划限制性股票回购价格及数量的公告浙江大洋生物科技集团股份有限公司于2026年8月3日召开第六届董事会第十次会议，审议通过《关于调整2025年股权激励计划限制性股票回购价格及数量的议案》。本次调整属于股东大会授权范围内，无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656055723","title":"股市必读：大洋生物新发布《第六届董事会第十次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656055723","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656055723?lang=zh_cn&edition=full","pubTime":"2026-08-04 01:36","pubTimestamp":1785778573,"startTime":"0","endTime":"0","summary":"相关议案已获董事会薪酬与考核委员会审议通过，关联董事已回避表决。董事会及薪酬与考核委员会确认本次解除限售合法合规。关于调整2025年股权激励计划限制性股票回购价格及数量的公告浙江大洋生物科技集团股份有限公司于2026年8月3日召开第六届董事会第十次会议，审议通过《关于调整2025年股权激励计划限制性股票回购价格及数量的议案》。本次调整属于股东大会授权范围内，无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656037744","title":"大洋生物（003017）披露2025年股权激励计划限制性股票第一个限售期解除限售条件成就公告，8月3日股价上涨2.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656037744","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656037744?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:33","pubTimestamp":1785767596,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，大洋生物报收于21.19元，较前一交易日上涨2.66%，最新总市值为21.36亿元。该股当日开盘20.68元，最高21.22元，最低20.67元，成交额达3939.99万元，换手率为2.26%。近日，浙江大洋生物科技集团股份有限公司召开董事会，审议通过2025年股权激励计划授予的限制性股票第一个解除限售期解除限售条件成就的议案。本次解除限售的股份数量为596,442股，涉及激励对象7人，占公司总股本的0.5916%。董事会及薪酬与考核委员会确认本次解除限售合法合规。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651989684","title":"股市必读：大洋生物（003017）7月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651989684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651989684?lang=zh_cn&edition=full","pubTime":"2026-07-16 02:23","pubTimestamp":1784139788,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，大洋生物报收于21.86元，下跌0.36%，换手率1.87%，成交量1.56万手，成交额3405.07万元。针对氯化钾等原材料成本波动，公司结合行业供需、下游客户采购规模及市场竞争格局调整碳酸钾售价，通过灵活定价机制对冲成本压力。公司已于2026年6月26日完成2025年年度权益分派实施，后续若推出新的规划，将及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600002242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651806414","title":"大洋生物：现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2651806414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651806414?lang=zh_cn&edition=full","pubTime":"2026-07-15 08:40","pubTimestamp":1784076020,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，6-9月国内禽类、水产养殖进入传统旺季，全球仅公司与辉宝两家盐酸氨丙啉供应商，以色列工厂地缘风险持续扰动供给： 1.当前600吨老产线是否维持满产，海外客户订单排单到几月，三季度产品售价是否存在上调空间？公司现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产，海外客户订单承接有序。公司年产800吨盐酸氨丙啉技改搬迁项目启动试产后，原有600吨老产线将结合监管要求与整体生产规划有序关停。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500009782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343715","title":"大洋生物（003017）披露完成工商登记变更并换发营业执照公告，6月30日股价上涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647343715?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:53","pubTimestamp":1782813184,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，大洋生物报收于23.0元，较前一交易日上涨7.03%，最新总市值为23.18亿元。近日，大洋生物披露《关于完成工商登记变更并换发营业执照的公告》。公告显示，公司于2026年4月24日召开第六届董事会第九次会议，并于2026年5月18日召开2025年年度股东会，审议通过了关于变更注册资本、经营范围并修订《公司章程》的议案。公司已完成工商变更登记及《公司章程》备案手续，并取得浙江省市场监督管理局核发的新营业执照。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536272","title":"6月30日大洋生物涨7.03%，长城行业轮动混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647536272?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:50","pubTimestamp":1782809430,"startTime":"0","endTime":"0","summary":"证券之星消息，6月30日大洋生物涨7.03%，收盘报23.0元，换手率5.47%，成交量4.55万手，成交额1.02亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城行业轮动混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000030381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536204","title":"大洋生物涨7.03%，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536204","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647536204?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:50","pubTimestamp":1782809421,"startTime":"0","endTime":"0","summary":"今日大洋生物涨7.03%，收盘报23.0元。2026年4月28日，开源证券研究员金益腾,蒋跨跃发布了对大洋生物的研报《公司信息更新报告：Q1业绩同环比增长，产业链布局逐步完善》，该研报对大洋生物给出“买入”评级。研报中预计2026-2028年归母净利润为1.67、2.21、2.42亿元，EPS为1.99、2.63、2.88元，当前股价对应PE为16.0、12.2、11.1倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为开源证券的蒋跨跃、金益腾。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000030377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646077365","title":"大洋生物（003017）披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告，6月26日股价上涨0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646077365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646077365?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:49","pubTimestamp":1782485353,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，大洋生物报收于21.63元，较前一交易日上涨0.19%，最新总市值为21.8亿元。该股当日开盘21.73元，最高22.22元，最低21.22元，成交额达4852万元，换手率为2.69%。近日，浙江大洋生物科技集团股份有限公司发布《关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告》。公司使用闲置募集资金进行现金管理不影响募投项目建设，未超出董事会授权额度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600046022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645309893","title":"大洋生物：现阶段相关产线正常生产，订单承接有序","url":"https://stock-news.laohu8.com/highlight/detail?id=2645309893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645309893?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:03","pubTimestamp":1782288196,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，全球盐酸氨丙啉仅两家供应，海外同行产能受限，想请教：1、2026年二季度盐酸氨丙啉新增海外订单同比是否明显增长？2、现有产线已满负荷生产的情况下，目前在手订单交付排期有多久？麻烦介绍下当前产能释放与订单承接情况，感谢！大洋生物回复：您好，感谢您对公司的关注。2026年第二季度的情况请关注公司披露的定期报告。现阶段相关产线正常生产，订单承接有序。待年产800吨搬迁扩建技改项目投产后，产能及交付能力会有所改善。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400026798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645933768","title":"大洋生物：下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线","url":"https://stock-news.laohu8.com/highlight/detail?id=2645933768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645933768?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:00","pubTimestamp":1782288046,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：据悉，鉴于目前盐酸氨丙啉供应局势，公司会综合考虑在下王工厂投产时，是否关闭现有600吨产能？大洋生物回复：您好，感谢您的关注。公司下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线，产线关停的具体实施节奏与时间节点将结合项目投产进度及行业监管相关要求推进。敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400026521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889337","title":"大洋生物：山东大洋新材料子公司预计2026年8-9月开始投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645889337?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:00","pubTimestamp":1782288044,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：山东大洋开始大量招聘操作工了，一期3万吨轻质预计什么时候投产大洋生物回复：您好，感谢您的关注。山东大洋新材料子公司预计2026年8-9月开始投产。实际投产日期受多重因素影响，敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400026517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229","159703"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645981898","title":"大洋生物：现阶段暂无进一步收购股权的相关计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2645981898","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645981898?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:39","pubTimestamp":1782286753,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问大洋生物有没有，后续收购、芯之纯半导体材料公司剩余股权的口头协议，或者书面协议呢？或者公司是计划赶在芯之纯产品量产的时候再收购吗？大洋生物回复：您好，感谢您的关注。公司目前持有芯之纯半导体材料有限公司30%股权，本次投资以战略投资为主，现阶段暂无进一步收购股权的相关计划。公司将持续跟踪芯之纯日常经营与业务发展动态，未来如涉及股权收购等重大事项，公司将严格按照监管规则及时履行信息披露义务。敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400023232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645905898","title":"大洋生物：除本公司与美国辉宝外全球暂未出现同等规模量产能力的第三方厂商","url":"https://stock-news.laohu8.com/highlight/detail?id=2645905898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645905898?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:39","pubTimestamp":1782286749,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，公司800吨盐酸氨丙啉技改项目即将投产，想了解行业供给情况：1、除公司与辉宝以外，全球是否还有其他具备同等交付能力的产能？辉宝工厂长期停产是否造成全球有效供给大幅收缩？除本公司与美国辉宝外，全球市场上目前暂未出现具备同等规模量产能力、稳定供货记录及完备合规资质的第三方厂商。部分企业虽有小规模量产规划或实验级产能，但与公司及辉宝在有效产能、批量交付能力上存在明显差距。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400023221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786688631105,"stockEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":-0.0105},{"period":"3month","weight":-0.2121},{"period":"6month","weight":-0.2036},{"period":"1year","weight":-0.2115},{"period":"ytd","weight":-0.1174}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江大洋生物科技集团股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"154660人(较上一季度增加1182.00%)","perCapita":"539股","listingDate":"2020-10-26","address":"浙江省杭州市建德市大洋镇朝阳路22号","registeredCapital":"10080万元","survey":" 浙江大洋生物科技集团股份有限公司的主营业务是基础化学原料制造和销售、化学产品制造和销售。公司的主要产品是无机盐产品、精细化工产品。公司是国家级专精特新“小巨人”。","listedPrice":28.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大洋生物,003017,大洋生物股票,大洋生物股票老虎,大洋生物股票老虎国际,大洋生物行情,大洋生物股票行情,大洋生物股价,大洋生物股市,大洋生物股票价格,大洋生物股票交易,大洋生物股票购买,大洋生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}